Literature DB >> 31563963

Automated machine learning based on radiomics features predicts H3 K27M mutation in midline gliomas of the brain.

Xiaorui Su1,2, Ni Chen3,2, Huaiqiang Sun1, Yanhui Liu4,2, Xibiao Yang5, Weina Wang1, Simin Zhang1, Qiaoyue Tan1, Jingkai Su1, Qiyong Gong1, Qiang Yue5,2.   

Abstract

BACKGROUND: Conventional MRI cannot be used to identify H3 K27M mutation status. This study aimed to investigate the feasibility of predicting H3 K27M mutation status by applying an automated machine learning (autoML) approach to the MR radiomics features of patients with midline gliomas.
METHODS: This single-institution retrospective study included 100 patients with midline gliomas, including 40 patients with H3 K27M mutations and 60 wild-type patients. Radiomics features were extracted from fluid-attenuated inversion recovery images. Prior to autoML analysis, the dataset was randomly stratified into separate 75% training and 25% testing cohorts. The Tree-based Pipeline Optimization Tool (TPOT) was applied to optimize the machine learning pipeline and select important radiomics features. We compared the performance of 10 independent TPOT-generated models based on training and testing cohorts using the area under the curve (AUC) and average precision to obtain the final model. An independent cohort of 22 patients was used to validate the best model.
RESULTS: Ten prediction models were generated by TPOT, and the accuracy obtained with the best pipeline ranged from 0.788 to 0.867 for the training cohort and from 0.60 to 0.84 for the testing cohort. After comparison, the AUC value and average precision of the final model were 0.903 and 0.911 in the testing cohort, respectively. In the validation set, the AUC was 0.85, and the average precision was 0.855 for the best model.
CONCLUSIONS: The autoML classifier using radiomics features of conventional MR images provides high discriminatory accuracy in predicting the H3 K27M mutation status of midline glioma.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  H3 K27M mutation automated machine learning; TPOT; Tree-based Pipeline Optimization Tool; autoML; midline glioma

Mesh:

Substances:

Year:  2020        PMID: 31563963      PMCID: PMC7442326          DOI: 10.1093/neuonc/noz184

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  29 in total

1.  Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.

Authors:  David A Solomon; Matthew D Wood; Tarik Tihan; Andrew W Bollen; Nalin Gupta; Joanna J J Phillips; Arie Perry
Journal:  Brain Pathol       Date:  2015-12-14       Impact factor: 6.508

2.  cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant.

Authors:  David N Louis; Caterina Giannini; David Capper; Werner Paulus; Dominique Figarella-Branger; M Beatriz Lopes; Tracy T Batchelor; J Gregory Cairncross; Martin van den Bent; Wolfgang Wick; Pieter Wesseling
Journal:  Acta Neuropathol       Date:  2018-03-01       Impact factor: 17.088

3.  Quantitative texture analysis in the prediction of IDH status in low-grade gliomas.

Authors:  Asgeir Store Jakola; Yi-Hua Zhang; Anne J Skjulsvik; Ole Solheim; Hans Kristian Bø; Erik Magnus Berntsen; Ingerid Reinertsen; Sasha Gulati; Petter Förander; Torkel B Brismar
Journal:  Clin Neurol Neurosurg       Date:  2017-12-05       Impact factor: 1.876

4.  Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.

Authors:  Elena V Daoud; Veena Rajaram; Chunyu Cai; Robert J Oberle; Gregory R Martin; Jack M Raisanen; Charles L White; Chan Foong; Bruce E Mickey; Edward Pan; Kimmo J Hatanpaa
Journal:  J Neuropathol Exp Neurol       Date:  2018-04-01       Impact factor: 3.685

5.  H3F3A K27M mutations in thalamic gliomas from young adult patients.

Authors:  Koki Aihara; Akitake Mukasa; Kengo Gotoh; Kuniaki Saito; Genta Nagae; Shingo Tsuji; Kenji Tatsuno; Shogo Yamamoto; Shunsaku Takayanagi; Yoshitaka Narita; Soichiro Shibui; Hiroyuki Aburatani; Nobuhito Saito
Journal:  Neuro Oncol       Date:  2013-11-26       Impact factor: 12.300

6.  Differentiation between spinal cord diffuse midline glioma with histone H3 K27M mutation and wild type: comparative magnetic resonance imaging.

Authors:  Jo Sung Jung; Yoon Seong Choi; Sung Soo Ahn; Seong Yi; Se Hoon Kim; Seung-Koo Lee
Journal:  Neuroradiology       Date:  2019-01-20       Impact factor: 2.804

7.  Computational Radiomics System to Decode the Radiographic Phenotype.

Authors:  Joost J M van Griethuysen; Andriy Fedorov; Chintan Parmar; Ahmed Hosny; Nicole Aucoin; Vivek Narayan; Regina G H Beets-Tan; Jean-Christophe Fillion-Robin; Steve Pieper; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

Review 8.  The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS).

Authors:  Bjoern H Menze; Andras Jakab; Stefan Bauer; Jayashree Kalpathy-Cramer; Keyvan Farahani; Justin Kirby; Yuliya Burren; Nicole Porz; Johannes Slotboom; Roland Wiest; Levente Lanczi; Elizabeth Gerstner; Marc-André Weber; Tal Arbel; Brian B Avants; Nicholas Ayache; Patricia Buendia; D Louis Collins; Nicolas Cordier; Jason J Corso; Antonio Criminisi; Tilak Das; Hervé Delingette; Çağatay Demiralp; Christopher R Durst; Michel Dojat; Senan Doyle; Joana Festa; Florence Forbes; Ezequiel Geremia; Ben Glocker; Polina Golland; Xiaotao Guo; Andac Hamamci; Khan M Iftekharuddin; Raj Jena; Nigel M John; Ender Konukoglu; Danial Lashkari; José Antonió Mariz; Raphael Meier; Sérgio Pereira; Doina Precup; Stephen J Price; Tammy Riklin Raviv; Syed M S Reza; Michael Ryan; Duygu Sarikaya; Lawrence Schwartz; Hoo-Chang Shin; Jamie Shotton; Carlos A Silva; Nuno Sousa; Nagesh K Subbanna; Gabor Szekely; Thomas J Taylor; Owen M Thomas; Nicholas J Tustison; Gozde Unal; Flor Vasseur; Max Wintermark; Dong Hye Ye; Liang Zhao; Binsheng Zhao; Darko Zikic; Marcel Prastawa; Mauricio Reyes; Koen Van Leemput
Journal:  IEEE Trans Med Imaging       Date:  2014-12-04       Impact factor: 10.048

9.  Targeted detection of genetic alterations reveal the prognostic impact of H3K27M and MAPK pathway aberrations in paediatric thalamic glioma.

Authors:  Scott Ryall; Rahul Krishnatry; Anthony Arnoldo; Pawel Buczkowicz; Matthew Mistry; Robert Siddaway; Cino Ling; Sanja Pajovic; Man Yu; Joshua B Rubin; Juliette Hukin; Paul Steinbok; Ute Bartels; Eric Bouffet; Uri Tabori; Cynthia Hawkins
Journal:  Acta Neuropathol Commun       Date:  2016-08-31       Impact factor: 7.801

10.  H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis.

Authors:  Bette K Kleinschmidt-DeMasters; Jean M Mulcahy Levy
Journal:  Clin Neuropathol       Date:  2018 Mar/Apr       Impact factor: 1.368

View more
  30 in total

1.  Automatic Machine Learning to Differentiate Pediatric Posterior Fossa Tumors on Routine MR Imaging.

Authors:  H Zhou; R Hu; O Tang; C Hu; L Tang; K Chang; Q Shen; J Wu; B Zou; B Xiao; J Boxerman; W Chen; R Y Huang; L Yang; H X Bai; C Zhu
Journal:  AJNR Am J Neuroradiol       Date:  2020-07       Impact factor: 3.825

2.  Prediction of H3K27M-mutant brainstem glioma by amide proton transfer-weighted imaging and its derived radiomics.

Authors:  Zhizheng Zhuo; Liying Qu; Peng Zhang; Liwei Zhang; Yaou Liu; Yunyun Duan; Dan Cheng; Xiaolu Xu; Ting Sun; Jinli Ding; Cong Xie; Xing Liu; Sven Haller; Frederik Barkhof
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-16       Impact factor: 9.236

3.  Non-invasive diagnosis of H3 K27M mutant midline glioma.

Authors:  Raymond Y Huang; Jeffrey P Guenette
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

4.  Radiogenomics of diffuse intrinsic pontine gliomas (DIPGs): correlation of histological and biological characteristics with multimodal MRI features.

Authors:  Raphaël Calmon; Volodia Dangouloff-Ros; Pascale Varlet; Christophe Deroulers; Cathy Philippe; Marie-Anne Debily; David Castel; Kevin Beccaria; Thomas Blauwblomme; David Grevent; Raphael Levy; Charles-Joris Roux; Yvonne Purcell; Ana Saitovitch; Monica Zilbovicius; Christelle Dufour; Stéphanie Puget; Jacques Grill; Nathalie Boddaert
Journal:  Eur Radiol       Date:  2021-05-18       Impact factor: 5.315

Review 5.  Advances in computed tomography-based prognostic methods for intracerebral hemorrhage.

Authors:  Xiaoyu Huang; Dan Wang; Shenglin Li; Qing Zhou; Junlin Zhou
Journal:  Neurosurg Rev       Date:  2022-02-28       Impact factor: 3.042

Review 6.  Prediction of H3 K27M-mutant in midline gliomas by magnetic resonance imaging: a systematic review and meta-analysis.

Authors:  Tiantian Hua; Zhizheng Zhuo; Liwei Zhang; Yaou Liu; Yunyun Duan; Xindi Li; Hongqiu Gu; Sven Haller; Peng Zhang; Xing Liu
Journal:  Neuroradiology       Date:  2022-04-13       Impact factor: 2.804

7.  Imaging characteristics of H3 K27M histone-mutant diffuse midline glioma in teenagers and adults.

Authors:  Stefanie Thust; Caroline Micallef; Sachi Okuchi; Sebastian Brandner; Atul Kumar; Kshitij Mankad; Stephen Wastling; Laura Mancini; Hans Rolf Jäger; Ananth Shankar
Journal:  Quant Imaging Med Surg       Date:  2021-01

8.  Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics.

Authors:  Qian Li; Fei Dong; Biao Jiang; Minming Zhang
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 9.  Machine Learning and Radiomics Applications in Esophageal Cancers Using Non-Invasive Imaging Methods-A Critical Review of Literature.

Authors:  Chen-Yi Xie; Chun-Lap Pang; Benjamin Chan; Emily Yuen-Yuen Wong; Qi Dou; Varut Vardhanabhuti
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

10.  Accelerating the Selection of Covalent Organic Frameworks with Automated Machine Learning.

Authors:  Peisong Yang; Huan Zhang; Xin Lai; Kunfeng Wang; Qingyuan Yang; Duli Yu
Journal:  ACS Omega       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.